Loading provider…
Loading provider…
Hematology & Oncology Physician in Toledo, OH
NPI: 1346247251Primary Practice Location
MERCY ST VINCENT MEDICAL CENTER
2600 Navarre Ave, Oregon, OH
Primary Employer
Toledo Clinic
toledoclinic.com
HQ Phone
Get MD Rex's Phone Numberphone_androidMobile
Get MD Rex's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 350 | 523 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 217 | 461 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 79 | 243 |
| 4 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 56 | 120 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 55 | 193 |
Authors: Charles Erlichman, Harry Yoon, Bassam Mattar, Preston Steen
Journal: Ann Oncol
Publication Date: 2015-11-16
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance).
Authors: Cary Gross, Alan Venook, Robert Mayer, Leonard Saltz, Daniel Atienza, Michael Messino, Charles Fuchs
Journal: JNCI Cancer Spectr
Publication Date: 2021-04-12
Authors: Karthik Giridhar, Winston Tan, Edith Perez, Alvaro Moreno-Aspitia, Gerald Gross, Richard Tenglin, Kostandinos Sideras
Journal: Oncologist
Publication Date: 2022-04-21
Lead Sponsor: Academic and Community Cancer Research United
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Pharmacological Study, OTHER: Quality-of-Life Assessment, DRUG: Regorafenib, DRUG: Clobetasol Propionate
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Bone Marrow Biopsy, DRUG: Venetoclax, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, PROCEDURE: Bone Marrow Aspiration, BIOLOGICAL: Obinutuzumab
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, DRUG: Gemcitabine Hydrochloride, DRUG: Paclitaxel, PROCEDURE: Computed Tomography, DRUG: Pemetrexed Disodium, PROCEDURE: Echocardiography Test, OTHER: Observation Activity